This commentary relates to the paper by Wong and Reiter \[[@B1]\], who report that basal cell carcinoma (BCC) can originate from the follicular bulge. Cytokeratins hetero-polymerise, with an acidic (type I) cytokeratin binding a neutral-basic (type II) cytokeratin. Cytokeratin 14 (K14) forms heterodimers with cytokeratin 5. In contrast, less is known about cytokeratin 15 (K15) and there is no known K15 binding partner (reviewed by \[[@B2]\]). During embryogenesis, postnatally, during wounding and in tumourigenesis, cytokeratins are differentially expressed in the basal layer of the mouse epidermis and in the hair follicle \[[@B2]\]. There is a relative lack of consensus among investigators, however, of marker specificity in terms of unequivocally identifying different subsets of stem cell.

It has been well established that K14 is expressed in the basal layer of the epidermis in postnatal mouse skin and can therefore be considered a marker for stem cells/progenitors in the basal layer of the epidermis \[[@B3]\]. K14 is, however, significantly less useful for distinguishing between progenitor cells in the basal layer and follicular bulge stem cells, as K14-expressing cells have also been described in the bulge of hair follicles (see, for example, \[[@B4],[@B5]\]).

Conversely, while K15 has been used as a marker for follicular stem cells in the bulge, K15 has been reported to also be expressed in the basal layer of the epidermis and to thus mark the least differentiated cells in the neonatal epidermis and adult bulge \[[@B6]\]. Likewise, in a careful recent study in which peptide-specific antibodies to K15 were used, it has been found that K15-immunoreactive cells are not exclusively limited to the follicular bulge, but that K15 is also expressed in cells of the basal layer of the mouse epidermis during embryo-genesis and throughout adulthood \[[@B2]\]. Thus, during the time of *SmoM2*activation in the study by Wong and Reiter \[[@B1]\], at 7.5 weeks of age, K15 is expressed not only in cells of the bulge but also by at least a subset of progenitor cells in the basal layer of the epidermis. Furthermore, K15 expression is down-regulated during wounding and in tumourigenesis. The lack of niche-specific gene expression and the dynamic changes in gene expression patterns during development, during the hair cycle, and in diseased skin poses a problem that consistently restricts interpretation of data in this field of investigation.

It is well established that bulge stem cells respond rapidly upon wounding and are recruited to the damaged area to seal the injury temporarily and in order to be replaced later on by basal layer-derived cells \[[@B7]\].

Wong and Reiter \[[@B1]\] have addressed the issue of K14 and K15 expression patterns in the two locations by quantifying β-galactosidase-expressing bulge follicular cells and cells in the epidermal basal layer in K14:*SmoM2*:LacZ and K15:*SmoM2*:LacZ mice. They have arrived at the same conclusion, that K14 and K15 are expressed by cells in both locations, albeit, as expected, in reciprocal ratios. The authors nevertheless suggest that wounding in the K15:*SmoM2*mouse recruits the tumour-prone bulge stem cells to the wounded area where the hedgehog pathway will be disinhibited, thus allowing tumourigenesis to be induced and to progress. While this may well be the case, strictly speaking the experiments shown in this study do not allow this conclusion. While known to occur in normal mice, migration of construct-expressing cells *per se*has not been shown in the current study. The data are limited to evidence of β-galactosidase-expressing cells in the basal layer of the epidermis. The cells could have immigrated from the bulge, but it is equally possible that they have been resident in the basal layer even prior to wounding and construct activation. Moreover, while admittedly difficult and possibly not achievable, a rigorous experimental design would not only show the dynamics of cell migration in these animal models of BCC, but also include as a control experiment the inhibition of cell migration from the bulge to the wound. In the latter case no tumour formation would be expected if the authors\' hypothesis were correct.

BCCs come in many variations - nodular basal-cell carcinoma (classic basal-cell carcinoma), cystic basal-cell carcinoma, cicatricial basal-cell carcinoma, infiltrative basal-cell carcinoma, micronodular basal-cell carcinoma, superficial basal-cell carcinoma, and pigmented basal-cell carcinoma. Due to this diversity of BCC, the most likely scenario is that BCC can have multiple origins that, depending on the specific type of tumour, originate from progenitor cells in the basal layer or the bulge. The existence of pigmented BBCs is intriguing, as neural crest-derived stem cells reside in the bulge of hair follicles \[[@B8]\] and neural crest-derived melanocyte precursors in the matrix differentiate into pigment cells that inject their melanosomes into keratinocytes and thus give hair its colour.
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